MARKET INTRODUCTION
Infectious diseases are crucial diseases to treat as the patients are under the higher risk of illness and vulnerability. The infection caused by the hospital contamination are widely seen in the hospital staffs and relatives of the patients. These infections are known as hospital acquired infections and these the common causes for mortality and morbidity. The HAI could been seen is patients through various factors such as surgical site infections, unhealthy premises of hospitals and others.
MARKET DYNAMICS
The hospital acquired infections (HAI) diagnostics market is estimated to grow significantly owing to key factors such as rising number of admission in hospitals, rising incidences of infectious diseases, growing cases for the chronic diseases and others. The market is expected to experience growth opportunities such as rising population, growing geriatric population, increasing numbers of hospitals and others.
MARKET SCOPE
The "Global Hospital Acquired Infections (HAI) Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of hospital acquired infections (HAI) diagnostics market with detailed market segmentation by infection type, diagnosis type, end user, and geography. The global hospital acquired infections (HAI) diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading hospital acquired infections (HAI) diagnostics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global hospital acquired infections (HAI) diagnostics market is segmented on the basis infection type, diagnosis type, end user. Based on the infection type the market is segmented as surgical site infections, blood stream infection, urinary tract infection, and others. On the basis of diagnosis type the market is segmented as molecular diagnosis, clinical diagnosis, and others. On the basis of end user segment the market is classified as hospitals, and diagnostic centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hospital acquired infections (HAI) diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hospital acquired infections (HAI) diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting hospital acquired infections (HAI) diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hospital acquired infections (HAI) diagnostics market in these regions.
MARKET PLAYERS
The reports cover key developments in the hospital acquired infections (HAI) diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from hospital acquired infections (HAI) diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for hospital acquired infections (HAI) diagnostics market in the global market. Below mentioned is the list of few companies engaged in the hospital acquired infections (HAI) diagnostics market.
The report also includes the profiles of key hospital acquired infections (HAI) diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Thermo Fisher Scientific Inc.
- Qiagen N.V
- Cepheid
- F. Hoffmann-La Roche AG
- Siemen AG
- Alere, Inc.
- bioMérieux SA
- Abbott
- BD
- Seegene, Inc.